共 161 条
- [1] Jones CM(2015)National and state treatment need and capacity for opioid agonist medication-assisted treatment Am J Public Health 105 e55-e63
- [2] Campopiano M(2014)Medication-assisted therapies—tackling the opioid-overdose epidemic N Engl J Med 370 2063-2066
- [3] Baldwin G(2015)The untapped potential of office-based buprenorphine treatment JAMA Psychiatry 72 395-340
- [4] McCance-Katz E(2016)Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment JAMA 316 1211-45
- [5] Volkow ND(2006)Attending physicians’ and residents’ attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital Fam Med 38 336-113
- [6] Frieden TR(2006)Evaluation of a combined online and in person training in the use of buprenorphine Subst Abus. 27 39-622
- [7] Hyde PS(2012)Practices, perceptions, and concerns of primary care physicians about opioid dependence associated with the treatment of chronic pain Subst Abus. 33 103-247
- [8] Cha SS(2014)Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency Am J Addict. 23 618-440
- [9] Sigmon SC(2013)A buprenorphine education and training program for primary care residents: implementation and evaluation Subst Abus. 34 242-251
- [10] Stein BD(2018)Training in office-based opioid treatment with buprenorphine in US residency programs: a national survey of residency program directors Subst Abus. 39 434-224